0001144204-18-064720.txt : 20181214 0001144204-18-064720.hdr.sgml : 20181214 20181214181424 ACCESSION NUMBER: 0001144204-18-064720 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181212 FILED AS OF DATE: 20181214 DATE AS OF CHANGE: 20181214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shah Rajeev M. CENTRAL INDEX KEY: 0001619841 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37926 FILM NUMBER: 181236583 MAIL ADDRESS: STREET 1: C/O CIVITAS THERAPEUTICS, INC. STREET 2: 190 EVERETT AVENUE CITY: CHELSEA STATE: MA ZIP: 02150 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ra Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001481512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262908274 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 87 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: (617) 401-4060 MAIL ADDRESS: STREET 1: 87 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 tv509215_4.xml OWNERSHIP DOCUMENT X0306 4 2018-12-12 0 0001481512 Ra Pharmaceuticals, Inc. RARX 0001619841 Shah Rajeev M. C/O RA CAPITAL MANAGEMENT, LLC 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116 1 0 1 0 Common Stock 2018-12-14 4 P 0 1006452 15.50 A 4858260 I See footnote These securities include 836,666 shares held by RA Capital Healthcare Fund, L.P. (the "Fund") and 169,786 shares held in an account owned by a separately managed account (the "Account"). Represents 3,971,750 shares of Common Stock held by the Fund and 886,510 shares of Common Stock held in the Account. RA Capital Management, LLC (the "Adviser") is the general partner of the Fund and the investment adviser of the Account. Peter Kolchinsky is the sole manager of the Adviser, and Mr. Shah is a managing director of the Adviser. Mr. Shah has no pecuniary interest in the reported securities held in the Account and therefore disclaims beneficial ownership of those securities. Mr. Shah disclaims beneficial ownership of the reported securities held by the Fund except to the extent of his pecuniary interest therein. /s/ Rajeev Shah 2018-12-14